Zhengye Biotechnology Stock (NASDAQ:ZYBT)
Previous Close
$2.02
52W Range
$1.40 - $14.30
50D Avg
$2.36
200D Avg
$5.84
Market Cap
$95.73M
Avg Vol (3M)
$400.96K
Beta
-
Div Yield
-
ZYBT Company Profile
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.